Skip to main content
icon for Flu Hospitalization Rate Week 16, 2026?

Flu Hospitalization Rate Week 16, 2026?

icon for Flu Hospitalization Rate Week 16, 2026?

Flu Hospitalization Rate Week 16, 2026?

85–90 100.0%

<80 <1%

80–85 <1%

90–95 <1%

Polymarket

$10,331 Vol.

85–90 100.0%

<80 <1%

80–85 <1%

90–95 <1%

Polymarket

$10,331 Vol.

<80

$728 Vol.

No

80–85

$2,893 Vol.

No

85–90

$3,655 Vol.

Yes

90–95

$1,610 Vol.

No

95–100

$805 Vol.

No

100+

$640 Vol.

No

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$10,331
Enddatum
1. Mai 2026
Markt eröffnet
Apr 24, 2026, 11:18 AM ET
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Vorgeschlagenes Ergebnis: No

Kein Einspruch

Endgültiges Ergebnis: No

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$10,331
Enddatum
1. Mai 2026
Markt eröffnet
Apr 24, 2026, 11:18 AM ET
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Vorgeschlagenes Ergebnis: No

Kein Einspruch

Endgültiges Ergebnis: No

Vorsicht bei externen Links.

Häufig gestellte Fragen

„Flu Hospitalization Rate Week 16, 2026?" ist ein Prognosemarkt auf Polymarket mit 6 möglichen Ergebnissen, bei dem Händler Anteile auf Basis ihrer Einschätzung kaufen und verkaufen. Das aktuell führende Ergebnis ist „85–90" mit 100%, gefolgt von „<80" mit 0%. Die Preise spiegeln Echtzeit-Wahrscheinlichkeiten der Community wider. Ein Anteilspreis von 100¢ bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 100% zuweist. Diese Quoten ändern sich laufend, wenn Händler auf neue Entwicklungen reagieren. Anteile am richtigen Ergebnis können bei Marktauflösung für jeweils $1 eingelöst werden.

Stand heute hat „Flu Hospitalization Rate Week 16, 2026?" ein Gesamthandelsvolumen von $10.3K generiert, seit der Markt am Apr 24, 2026 gestartet wurde. Dieses Aktivitätsniveau spiegelt starkes Engagement der Polymarket-Community wider und stellt sicher, dass die aktuellen Quoten von einem breiten Pool an Marktteilnehmern geprägt werden. Sie können Live-Preisbewegungen verfolgen und direkt auf dieser Seite auf jedes Ergebnis handeln.

Um auf „Flu Hospitalization Rate Week 16, 2026?" zu handeln, durchsuchen Sie die 6 verfügbaren Ergebnisse auf dieser Seite. Jedes Ergebnis zeigt einen aktuellen Preis, der die implizierte Wahrscheinlichkeit des Marktes darstellt. Um eine Position einzunehmen, wählen Sie das Ergebnis, das Sie für am wahrscheinlichsten halten, wählen Sie „Ja" um dafür oder „Nein" um dagegen zu handeln, geben Sie Ihren Betrag ein und klicken Sie auf „Handeln". Liegt Ihr gewähltes Ergebnis bei Marktauflösung richtig, zahlen Ihre „Ja"-Anteile jeweils $1 aus. Liegt es falsch, zahlen sie $0. Sie können Ihre Anteile auch jederzeit vor der Auflösung verkaufen.

Der aktuelle Favorit für „Flu Hospitalization Rate Week 16, 2026?" ist „85–90" mit 100%, was bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 100% zuweist. Das nächstliegende Ergebnis ist „<80" mit 0%. Diese Quoten werden in Echtzeit aktualisiert, wenn Händler Anteile kaufen und verkaufen. Schauen Sie regelmäßig vorbei oder speichern Sie diese Seite als Lesezeichen.

Die Auflösungsregeln für „Flu Hospitalization Rate Week 16, 2026?" definieren genau, was passieren muss, damit jedes Ergebnis als Gewinner erklärt wird – einschließlich der offiziellen Datenquellen zur Bestimmung des Ergebnisses. Sie können die vollständigen Auflösungskriterien im Abschnitt „Regeln" auf dieser Seite über den Kommentaren einsehen. Wir empfehlen, die Regeln vor dem Handeln sorgfältig zu lesen, da sie die genauen Bedingungen, Sonderfälle und Quellen festlegen.